Palvella Therapeutics Inc (PVLA)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
28.14 +0.71 (+2.59%) 03/21/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 28.14 unch (unch) 16:01 ET
for Fri, Mar 21st, 2025
Results
download Want to compare other data? Select Fields| Symbol | PVLA | CMPX | GOSS | ||
| Company | Palvella Therapeutics Inc | Compass Therapeutics Inc | Gossamer Bio Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 27.36 | 2.21 | 1.3400 | ||
| High | 28.81 | 2.34 | 1.4100 | ||
| Low | 26.72 | 2.21 | 1.3050 | ||
| Last | 28.14 | 2.31 | 1.3900 | ||
| Change | +0.71 | +0.07 | +0.0400 | ||
| % Change | +2.59% | +3.12% | +2.96% | ||
| Volume | 455,200 | 1,021,000 | 1,070,400 | ||
| 20-Day Average Volume | 82,090 | 814,805 | 1,605,050 | ||
| Previous Close | 27.43 | 2.24 | 1.3500 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 24.14 | 2.61 | 1.2785 | ||
| 20-Day Raw Stochastic | 89.47% | 11.30% | 76.84% | ||
| 20-Day Relative Strength | 73.79% | 42.43% | 57.98% | ||
| Weighted Alpha | +12.21 | -9.34 | +8.95 | ||
| Today's Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Previous Opinion | 100% Buy | 40% Buy | 100% Buy | ||
| Last Month's Opinion | 72% Buy | 88% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +2.46% since 03/14/25 | -6.10% since 03/14/25 | -4.14% since 03/14/25 | ||
| Low | 26.17 on 03/17/25 | 2.18 on 03/19/25 | 1.3000 on 03/17/25 | ||
| High | 28.81 on 03/21/25 | 2.61 on 03/17/25 | 1.4500 on 03/17/25 | ||
| 1-Month | |||||
| %Chg | +46.41% since 02/21/25 | -20.89% since 02/21/25 | -0.71% since 02/21/25 | ||
| Low | 18.54 on 02/26/25 | 2.18 on 03/19/25 | 1.0950 on 03/10/25 | ||
| High | 29.27 on 03/13/25 | 3.33 on 02/24/25 | 1.4789 on 03/14/25 | ||
| 3-Month | |||||
| %Chg | +133.53% since 12/20/24 | +67.39% since 12/20/24 | +65.48% since 12/20/24 | ||
| Low | 11.17 on 12/30/24 | 1.40 on 01/02/25 | 0.8001 on 12/23/24 | ||
| High | 29.27 on 03/13/25 | 4.08 on 02/11/25 | 1.5500 on 02/20/25 | ||
| 6-Month | |||||
| %Chg | +63.23% since 09/20/24 | +39.16% since 09/20/24 | +32.38% since 09/20/24 | ||
| Low | 11.17 on 12/30/24 | 1.27 on 11/18/24 | 0.6617 on 11/21/24 | ||
| High | 29.27 on 03/13/25 | 4.08 on 02/11/25 | 1.5500 on 02/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 307,792 | 309,754 | 306,748 | ||
| Shares Outstanding, K | 11,221 | 138,283 | 227,221 | ||
| Annual Sales | 42,810,000 | 850,000 | 114,700,000 | ||
| Annual Net Income | -24,540,000 | -49,380,000 | -56,530,000 | ||
| Last Quarter Sales | 0 | 0 | 9,380,000 | ||
| Last Quarter Net Income | -3,590,000 | -10,480,000 | -33,030,000 | ||
| 60-Month Beta | 0.54 | 1.19 | 1.86 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -2.19 on 11/13/24 | -0.11 on 02/27/25 | -0.15 on 03/13/25 | ||
| Latest Earnings Date | 03/31/25 | 05/12/25 | 05/06/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||